Rasmusson I - Search Results

1

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Ringdén O, et al. Among authors: rasmusson i. Transplantation. 2006 May 27;81(10):1390-7. doi: 10.1097/01.tp.0000214462.63943.14. Transplantation. 2006. PMID: 16732175 Clinical Trial.

2

Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

Sundin M, Orvell C, Rasmusson I, Sundberg B, Ringdén O, Le Blanc K. Sundin M, et al. Among authors: rasmusson i. Bone Marrow Transplant. 2006 Jun;37(11):1051-9. doi: 10.1038/sj.bmt.1705368. Bone Marrow Transplant. 2006. PMID: 16604097

3

Mesenchymal stem cells stimulate antibody secretion in human B cells.

Rasmusson I, Le Blanc K, Sundberg B, Ringdén O. Rasmusson I, et al. Scand J Immunol. 2007 Apr;65(4):336-43. doi: 10.1111/j.1365-3083.2007.01905.x. Scand J Immunol. 2007. PMID: 17386024 Free article.

4

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.

Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Rasmusson I, et al. Transplantation. 2003 Oct 27;76(8):1208-13. doi: 10.1097/01.TP.0000082540.43730.80. Transplantation. 2003. PMID: 14578755

5

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. Le Blanc K, et al. Among authors: rasmusson i. Lancet. 2004 May 1;363(9419):1439-41. doi: 10.1016/S0140-6736(04)16104-7. Lancet. 2004. PMID: 15121408

6

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.

Le Blanc K, Rasmusson I, Götherström C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringdén O. Le Blanc K, et al. Among authors: rasmusson i. Scand J Immunol. 2004 Sep;60(3):307-15. doi: 10.1111/j.0300-9475.2004.01483.x. Scand J Immunol. 2004. PMID: 15320889 Free article.

7

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Rasmusson I, et al. Exp Cell Res. 2005 Apr 15;305(1):33-41. doi: 10.1016/j.yexcr.2004.12.013. Epub 2005 Jan 25. Exp Cell Res. 2005. PMID: 15777785

8

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.

Rasmusson I, Uhlin M, Le Blanc K, Levitsky V. Rasmusson I, et al. J Leukoc Biol. 2007 Oct;82(4):887-93. doi: 10.1189/jlb.0307140. Epub 2007 Jul 3. J Leukoc Biol. 2007. PMID: 17609339

9

Immune modulation by mesenchymal stem cells.

Rasmusson I. Rasmusson I. Exp Cell Res. 2006 Jul 15;312(12):2169-79. doi: 10.1016/j.yexcr.2006.03.019. Epub 2006 Apr 24. Exp Cell Res. 2006. PMID: 16631737 Review.

10

Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization.

Johansson U, Rasmusson I, Niclou SP, Forslund N, Gustavsson L, Nilsson B, Korsgren O, Magnusson PU. Johansson U, et al. Among authors: rasmusson i. Diabetes. 2008 Sep;57(9):2393-401. doi: 10.2337/db07-0981. Epub 2008 Jun 2. Diabetes. 2008. PMID: 18519803 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters